These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 1570015)

  • 1. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
    Basu TN; Gutmann DH; Fletcher JA; Glover TW; Collins FS; Downward J
    Nature; 1992 Apr; 356(6371):713-5. PubMed ID: 1570015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of rasGAP and neurofibromatosis gene product activities.
    Bollag G; McCormick F
    Nature; 1991 Jun; 351(6327):576-9. PubMed ID: 1904555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular genetics of neurofibromatosis type 1].
    Suzuki H; Takahashi K; Shibahara S
    Nihon Rinsho; 1993 Sep; 51(9):2457-61. PubMed ID: 8411728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
    Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B; Bollag G; Shannon K
    Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
    Guha A; Lau N; Huvar I; Gutmann D; Provias J; Pawson T; Boss G
    Oncogene; 1996 Feb; 12(3):507-13. PubMed ID: 8637706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras regulation. NF is enough of GAP.
    Bollag G; McCormick F
    Nature; 1992 Apr; 356(6371):663-4. PubMed ID: 1570011
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
    Marshall MS; Hettich LA
    Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Ras signaling pathway by GTPase-activating protein in PC12 cells.
    Yao R; Cooper GM
    Oncogene; 1995 Oct; 11(8):1607-14. PubMed ID: 7478585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of c-ras transformation by GTPase-activating protein.
    Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
    Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway.
    Buchberg AM; Cleveland LS; Jenkins NA; Copeland NG
    Nature; 1990 Sep; 347(6290):291-4. PubMed ID: 2169593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory mechanisms for ras proteins.
    Downward J
    Bioessays; 1992 Mar; 14(3):177-84. PubMed ID: 1586371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between p21ras proteins and their GTPase activating proteins.
    Polakis P; McCormick F
    Cancer Surv; 1992; 12():25-42. PubMed ID: 1386285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
    Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
    Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
    Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
    Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
    Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
    Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NF1 (neurofibromatosis type 1)].
    Maruta H; Nur-e-Kamal
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1422-6. PubMed ID: 9309135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.